GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MZF1 | hg19_v2_chr19_-_59084647_59084721 | 0.42 | 9.6e-11 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_61765315 Show fit | 24.96 |
ENST00000406957.1
ENST00000401558.2 |
exportin 1 (CRM1 homolog, yeast) |
|
chr17_+_4618734 Show fit | 24.50 |
ENST00000571206.1
|
arrestin, beta 2 |
|
chr4_-_84035905 Show fit | 20.71 |
ENST00000311507.4
|
placenta-specific 8 |
|
chr4_-_84035868 Show fit | 19.47 |
ENST00000426923.2
ENST00000509973.1 |
placenta-specific 8 |
|
chr17_-_47841485 Show fit | 19.23 |
ENST00000506156.1
ENST00000240364.2 |
family with sequence similarity 117, member A |
|
chr16_+_69958887 Show fit | 19.20 |
ENST00000568684.1
|
WW domain containing E3 ubiquitin protein ligase 2 |
|
chr11_-_46142615 Show fit | 17.57 |
ENST00000529734.1
ENST00000323180.6 |
PHD finger protein 21A |
|
chr12_-_15114603 Show fit | 15.95 |
ENST00000228945.4
|
Rho GDP dissociation inhibitor (GDI) beta |
|
chr11_-_46142948 Show fit | 15.85 |
ENST00000257821.4
|
PHD finger protein 21A |
|
chr1_-_153518270 Show fit | 15.11 |
ENST00000354332.4
ENST00000368716.4 |
S100 calcium binding protein A4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.4 | 52.2 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.5 | 47.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.9 | 45.9 | GO:0043486 | histone exchange(GO:0043486) |
2.5 | 40.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
7.3 | 29.4 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.1 | 28.8 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
3.6 | 25.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
3.0 | 23.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.0 | 23.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
6.8 | 20.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 50.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.4 | 47.4 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.4 | 44.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 43.9 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
1.8 | 37.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 34.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.6 | 33.4 | GO:1990391 | DNA repair complex(GO:1990391) |
1.6 | 25.2 | GO:0097346 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) INO80-type complex(GO:0097346) |
3.6 | 25.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 23.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.4 | 52.2 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
1.3 | 51.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 46.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.8 | 44.9 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.6 | 33.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
2.9 | 29.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 28.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.5 | 28.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
1.7 | 25.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
2.2 | 23.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 55.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.7 | 51.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.5 | 36.2 | PID P53 REGULATION PATHWAY | p53 pathway |
1.4 | 35.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 32.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.9 | 28.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.7 | 25.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 22.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.0 | 19.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 19.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 55.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 44.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 38.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.9 | 25.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.5 | 24.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 24.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.1 | 22.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 21.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.0 | 17.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.4 | 17.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |